306 related articles for article (PubMed ID: 31833093)
1. Dendritic cells: The driver of psoriasis.
Wang A; Bai Y
J Dermatol; 2020 Feb; 47(2):104-113. PubMed ID: 31833093
[TBL] [Abstract][Full Text] [Related]
2. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
[TBL] [Abstract][Full Text] [Related]
3. The Origin of Skin Dendritic Cell Network and Its Role in Psoriasis.
Kim TG; Kim SH; Lee MG
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295520
[TBL] [Abstract][Full Text] [Related]
4. Highly Effective New Treatments for Psoriasis Target the IL-23/Type 17 T Cell Autoimmune Axis.
Kim J; Krueger JG
Annu Rev Med; 2017 Jan; 68():255-269. PubMed ID: 27686018
[TBL] [Abstract][Full Text] [Related]
5. Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.
Oehrl S; Olaru F; Kunze A; Maas M; Pezer S; Schmitz M; Schäkel K
J Dermatol Sci; 2017 Sep; 87(3):278-284. PubMed ID: 28732748
[TBL] [Abstract][Full Text] [Related]
6. p38α signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation.
Zheng T; Zhao W; Li H; Xiao S; Hu R; Han M; Liu H; Liu Y; Otsu K; Liu X; Huang G
Sci Signal; 2018 Mar; 11(521):. PubMed ID: 29535261
[TBL] [Abstract][Full Text] [Related]
7. Suppressive effect of β, β-dimethylacryloyl alkannin on activated dendritic cells in an imiquimod-induced psoriasis mouse model.
Wang Y; Zhao J; Zhang L; Di T; Liu X; Lin Y; Zeng Z; Li P
Int J Clin Exp Pathol; 2015; 8(6):6665-73. PubMed ID: 26261548
[TBL] [Abstract][Full Text] [Related]
8. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.
Brunner PM; Koszik F; Reininger B; Kalb ML; Bauer W; Stingl G
J Allergy Clin Immunol; 2013 Nov; 132(5):1184-1193.e8. PubMed ID: 23890755
[TBL] [Abstract][Full Text] [Related]
9. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.
Zaba LC; Suárez-Fariñas M; Fuentes-Duculan J; Nograles KE; Guttman-Yassky E; Cardinale I; Lowes MA; Krueger JG
J Allergy Clin Immunol; 2009 Nov; 124(5):1022-10.e1-395. PubMed ID: 19895991
[TBL] [Abstract][Full Text] [Related]
10. The Role of IL-17 in the Pathogenesis of Psoriasis and Update on IL-17 Inhibitors for the Treatment of Plaque Psoriasis.
AbuHilal M; Walsh S; Shear N
J Cutan Med Surg; 2016 Nov; 20(6):509-516. PubMed ID: 27207350
[TBL] [Abstract][Full Text] [Related]
11. Specific roles for dendritic cell subsets during initiation and progression of psoriasis.
Glitzner E; Korosec A; Brunner PM; Drobits B; Amberg N; Schonthaler HB; Kopp T; Wagner EF; Stingl G; Holcmann M; Sibilia M
EMBO Mol Med; 2014 Oct; 6(10):1312-27. PubMed ID: 25216727
[TBL] [Abstract][Full Text] [Related]
12. Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.
Günther C; Blau K; Förster U; Viehweg A; Wozel G; Schäkel K
Exp Dermatol; 2013 Aug; 22(8):535-40. PubMed ID: 23879812
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines.
Fitch E; Harper E; Skorcheva I; Kurtz SE; Blauvelt A
Curr Rheumatol Rep; 2007 Dec; 9(6):461-7. PubMed ID: 18177599
[TBL] [Abstract][Full Text] [Related]
14. The vitamin D
Hau CS; Shimizu T; Tada Y; Kamata M; Takeoka S; Shibata S; Mitsui A; Asano Y; Sugaya M; Kadono T; Sato S; Watanabe S
J Dermatol Sci; 2018 Nov; 92(2):117-126. PubMed ID: 30166055
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis.
Yawalkar N; Tscharner GG; Hunger RE; Hassan AS
J Dermatol Sci; 2009 May; 54(2):99-105. PubMed ID: 19264456
[TBL] [Abstract][Full Text] [Related]
16. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541
[TBL] [Abstract][Full Text] [Related]
17. Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα - IL-23 - IL-17 Axis.
Kubin ME; Kokkonen N; Palatsi R; Hägg PM; Väyrynen JP; Glumoff V; Haapasaari KM; Hurskainen T; Tasanen K
Acta Derm Venereol; 2017 Apr; 97(4):449-455. PubMed ID: 27868150
[TBL] [Abstract][Full Text] [Related]
18. New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors.
Gaspari AA; Tyring S
Dermatol Ther; 2015; 28(4):179-93. PubMed ID: 26201310
[TBL] [Abstract][Full Text] [Related]
19. Identification of cellular pathways of "type 1," Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis.
Haider AS; Lowes MA; Suárez-Fariñas M; Zaba LC; Cardinale I; Khatcherian A; Novitskaya I; Wittkowski KM; Krueger JG
J Immunol; 2008 Feb; 180(3):1913-20. PubMed ID: 18209089
[TBL] [Abstract][Full Text] [Related]
20. Distinctive downmodulation of plasmacytoid dendritic cell functions by vitamin D3 analogue calcipotriol.
Suzuki T; Tatsuno K; Ito T; Sakabe JI; Funakoshi A; Tokura Y
J Dermatol Sci; 2016 Oct; 84(1):71-79. PubMed ID: 27342039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
